Patent & IP news for January 12, 2017

Update on P3 Program from dunlapcodding.com

Ann Robl

The Post-Prosecution Pilot (“P3”) Program closed today, January 12, at the end of its six-month run.  According to the USPTO, all of the technology centers met their limit of 200 requests, except for ...

Share via E–mail | Twitter | Facebook

Petitioner’s Inability to Cross-Examine Patent Owner’s Expert Justifies Motion to Strike Expert’s Declaration from docketreport.blogspot.com

During a conference call, the Board granted the petitioner authorization to file a motion to strike the declaration of the patent owner's expert because the expert was unavailable for deposition prior to the due ...

Share via E–mail | Twitter | Facebook

Samsung v. Apple: Back before the Federal Circuit on Design Patent Damages from patentlyo.com

In a one-paragraph order, the Federal Circuit has vacated its prior design patent damages determination in Samsung v. Apple following the Supreme Court’s 2016 reversal.  The appeal is reinstated, and new briefs will now ...

Share via E–mail | Twitter | Facebook

USPTO 2016 Performance and Accountability Report from patentlyo.com

By Jason Rantanen Last week, the United States Patent and Trademark Office released its annual Performance and Accountability Report.  If you’ve never read this document before, I highly encourage giving it a look.  It ...

Share via E–mail | Twitter | Facebook

CAFC affirms SD Ind in Lilly v. Teva in pemetrexed case Teva loses; from ipbiz.blogspot.com


The overview of the action:


Eli Lilly & Co. (“Eli Lilly”) is the owner of U.S. Patent
No. 7,772,209 (“’209 patent”). It filed this consolidated
Hatch-Waxman suit against Teva Parenteral Medicines,
Inc.; APP ...

Share via E–mail | Twitter | Facebook

Ninth Circuit Oral Argument in App Store Antitrust Litigation from www.717madisonplace.com

There was a decision from the Ninth Circuit today that deals with an antitrust suit brought against Apple with respect to the Apple App Store.  You can review the decision here: [Link].  You can review ...

Share via E–mail | Twitter | Facebook